Pulike Biological Engineering, Inc. (603566.SS)
CNY 13.78
(1.32%)
CNY 13.78
(1.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 282.77 Million | 233.12 Million | 212.53 Million | 261.83 Million | 140.1 Million | 126.27 Million |
| Net Income | 174.51 Million | 174.11 Million | 244.13 Million | 227.74 Million | 109.24 Million | 135.61 Million |
| Depreciation & Amortization | 92.72 Million | 73.81 Million | 59.46 Million | 51.05 Million | 50.37 Million | 41.91 Million |
| Deferred income taxes | -305.31 Thousand | -9.23 Million | 3.18 Million | 3.85 Million | 2.04 Million | 625.87 Thousand |
| Stock-based compensation | - | - | - | - | - | -4.58 Million |
| Change in working capital | -15.26 Million | -49.42 Million | -91.52 Million | 8.87 Million | -8.35 Million | -37.33 Million |
| Other non-cash items | 1.22 Million | 34.61 Million | 461.58 Thousand | -25.84 Million | -11.16 Million | -13.91 Million |
| Investing Cash Flow | -1.66 Million | -956.28 Million | -130.5 Million | -107.74 Million | -184.41 Million | 140.4 Million |
| Investments in PPE | -304.98 Million | -356.75 Million | -317.54 Million | -177.13 Million | -85.17 Million | -53.61 Million |
| Acquisitions | -23.13 Million | 447.75 Thousand | 1.07 Million | 178.05 Million | -69.43 Million | 53.71 Million |
| Investment purchases | -2.11 Billion | -818.77 Million | -506.67 Million | -866.2 Million | -1.29 Billion | -1.84 Billion |
| Sales/Maturities of investments | 2.43 Billion | 218.79 Million | 692.64 Million | 934.67 Million | 1.26 Billion | 2.03 Billion |
| Other Investing Activities | 326.45 Million | 1.04 | 0.83 | -177.13 Million | 59.78 Thousand | -53.61 Million |
| Financing Cash Flow | -241.02 Million | 829.07 Million | -157.57 Million | -196.72 Million | -110.64 Million | -78.98 Million |
| Debt repayment | -7 Million | -30 Million | - | - | - | - |
| Dividends payments | -224.94 Million | -62.92 Million | -157.32 Million | -63.18 Million | -96.01 Million | -64.67 Million |
| Common Stock Repurchased | -7.64 Million | - | - | -133.54 Million | -13.19 Million | -14.3 Million |
| Common Stock Issuance | - | - | -150 Thousand | - | - | - |
| Other Financing Activities | -9.02 Million | 922.72 Million | -253.51 Thousand | -0.22 | -0.90 | -14.3 Million |
| Accounts receivables | -6.42 Million | -219.97 Million | -102.26 Million | -57.07 Million | 14.72 Million | -49.79 Million |
| Accounts payables | -16.42 Million | 198.88 Million | 44.3 Million | 77.85 Million | -16.02 Million | 37.31 Million |
| Inventory | 7.89 Million | -19.1 Million | -36.74 Million | -15.75 Million | -9.1 Million | -25.47 Million |
| Other working capital | 5.05 Million | -9.23 Million | 3.18 Million | 3.85 Million | 2.04 Million | -11.85 Million |
| Cash at beginning of period | 271.37 Million | 164.5 Million | 240.27 Million | 282.91 Million | 437.88 Million | 250.19 Million |
| Cash at end of period | 311.77 Million | 270.76 Million | 164.5 Million | 240.27 Million | 282.91 Million | 437.88 Million |
| Capital Expenditure | -304.98 Million | -356.75 Million | -317.54 Million | -177.13 Million | -85.17 Million | -53.61 Million |
| Effect of forex changes on cash | 311.47 Thousand | 340.84 Thousand | -215.92 Thousand | -2905.05 | -13.05 Thousand | - |
| Net cash flow / Change in cash | 40.39 Million | 106.25 Million | -75.76 Million | -42.64 Million | -154.97 Million | 187.69 Million |
| Free Cash Flow | -22.2 Million | -123.62 Million | -105 Million | 84.69 Million | 54.92 Million | 72.65 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 32.32 Million | 46.63 Million | 27.3 Million | -4.59 Million | 174.51 Million | 61.61 Million |
| Depreciation & Amortization | - | 28.84 Million | 28.84 Million | 92.72 Million | 92.72 Million | 41.32 Million |
| Deferred income taxes | - | - | - | - | -305.31 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -8.58 Million | - | 6.52 Million | -15.26 Million | - |
| Other non-cash items | 48.48 Million | 30.77 Million | -18.25 Million | -1.17 Million | 1.22 Million | 52.37 Million |
| Investing Cash Flow | -198.37 Million | 260.4 Million | -109.14 Million | 57.05 Million | -1.66 Million | -49.11 Million |
| Investments in PPE | -11.6 Million | -11.6 Million | -61.15 Million | -50.69 Million | -304.98 Million | -48.29 Million |
| Acquisitions | 227.06 Thousand | 10.22 Thousand | 970.00 | -23.13 Million | -23.13 Million | 100.00 |
| Investment purchases | -564.67 Million | -364 Million | -333.52 Million | -378.28 Million | -2.11 Billion | -390.13 Million |
| Sales/Maturities of investments | 377.67 Million | 635.99 Million | 285.53 Million | 508.92 Million | 2.43 Billion | 389.31 Million |
| Other Investing Activities | - | 268.16 Million | -34.54 Million | 130.88 Million | 326.45 Million | 0.86 |
| Financing Cash Flow | -19.89 Million | -153.01 Million | -17.76 Million | -138.82 Million | -241.02 Million | -22.37 Million |
| Debt repayment | - | - | - | - | -7 Million | - |
| Dividends payments | - | -137.84 Million | - | -224.81 Million | -224.94 Million | - |
| Common Stock Repurchased | 32.93 Million | -32.93 Million | - | -1.6 Million | -7.64 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -52.83 Million | -120.07 Million | -17.76 Million | -35 Million | -9.02 Million | -22.37 Million |
| Accounts receivables | - | 7.14 Million | - | -6.42 Million | -6.42 Million | - |
| Accounts payables | - | - | - | - | -16.42 Million | - |
| Inventory | - | -11.81 Million | - | 7.89 Million | 7.89 Million | - |
| Other working capital | - | -3.91 Million | - | 5.05 Million | 5.05 Million | - |
| Cash at beginning of period | 357.82 Million | 198.45 Million | 306.62 Million | 299.74 Million | 271.37 Million | 257.23 Million |
| Cash at end of period | 220.2 Million | 357.82 Million | 198.45 Million | 311.77 Million | 311.77 Million | 299.74 Million |
| Capital Expenditure | -11.6 Million | -11.6 Million | -61.15 Million | -50.69 Million | -304.98 Million | -48.29 Million |
| Effect of forex changes on cash | - | 109.59 Thousand | 37.21 Thousand | 308.81 Thousand | 311.47 Thousand | 4233.69 |
| Net cash flow / Change in cash | -137.61 Million | 159.36 Million | -108.16 Million | 12.02 Million | 40.39 Million | 42.51 Million |
| Free Cash Flow | 69.2 Million | 36.96 Million | -52.09 Million | 42.78 Million | -22.2 Million | 65.69 Million |
3557
HATSUN
MGIC
MPAC
YZCFF
HEIJM